HIV and AIDS

This webpage from Texas Health and Human Services discusses HIV in women. This webpage offers various infographics, sharable graphics, and fast facts on HIV in women.

Controlling prescription drug expenditures is a priority for all state and territorial ADAPs providing antiretrovirals and other essential medications to uninsured and underinsured people with HIV. Indeed, good stewardship of federal funds requires ADAPs to acquire and pay for drugs in the most economical manner feasible.

PrEP (pre-exposure prophylaxis) is medicine people take to prevent getting HIV from sex or injection drug use. This video provides information about PrEP.

This video provides information about HIV testing, prevention, and treatment.

This informational video discusses HIV and best practices for HIV prevention. 

This informational video discusses Post Exposure Prophylaxis (PEP). It includes verbal narration as well as signed American Sign Language.

This informational video discusses the PrEP pill. It includes verbal narration as well as signed American Sign Language.

This webinar features an exchange between Project Manager, Ciarra "Ci Ci" Covin (The Well Project) and Latesha Elopre, MD, MSPH (University of Alabama at Birmingham) to uplift the unique needs and priorities and insights of Black women living with and vulnerable to HIV, with an emphasis on the US South. It also highlights optimal care for women and provide participants with best practices to improve their capacity to serve the needs of women living with and vulnerable to HIV. This program is supported through a grant from NASTAD.

RAISE and NASTAD’s webinar, “Program Evaluation Essentials for EHE” took place on Tuesday, January 23, 2024. Dr. Roxanne Kerani discussed key evaluation methods and provided applied examples of public health HIV program evaluations. 

This guideline discusses pharmaceutical company patient assistance programs and cost-sharing assistance programs for HIV treatment.